Medications

US approves Sanofi, Regeneron arthritis drug

US federal regulators have given the green light to French pharmaceutical company Sanofi and its US partner Regeneron to market a drug to treat the chronic inflammatory condition, rheumatoid arthritis.

page 5 from 9